Log in
Enquire now
GentiBio

GentiBio

GentiBio, Inc. is a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
Company Operating Status
Active
Contact Page URL
gentibio.com/contact/
Crunchbase URL
crunchbase.com/organiz...gentibio
Industry
Healthcare
Healthcare
Regenerative medicine
Regenerative medicine
Biotechnology
Biotechnology
Gene therapy
Gene therapy
Cell therapy
Cell therapy
Stem cell
Stem cell
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Immunotherapy
Immunotherapy
T cell
T cell
Latest Funding Round Date
August 16, 2021
Latest Funding Round Amount (USD)
157,000,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/gentibio
Location
Seattle
Seattle
Washington (state)
Washington (state)
Pitchbook URL
pitchbook.com/profiles...437804-74
Total Funding Amount (USD)
177,000,000
Twitter URL
@gentibio
Official Website
gentibio.com

Find more companies like GentiBio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.